Related Experiment Video
Updated: May 13, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
[Hypereosinophilic syndrome]
F Moosig1, G Richardt, C Merten
1Klinikum Bad Bramstedt und Universitätsklinikum Schleswig-Holstein, Oskar-Alexander-Str. 26, 24576 Bad Bramstedt. f.moosig@klinikumbb.de
Hypereosinophilic syndrome involves high eosinophil counts and organ damage. Diagnosis and identifying the cause are key for treatment and prognosis, especially when the heart is involved.
Area of Science:
- Hematology
- Immunology
- Pathology
Context:
- Hypereosinophilic syndrome (HES) is a complex group of disorders.
- Characterized by elevated blood eosinophils and resultant organ damage.
- Requires thorough investigation to determine underlying causes and affected organs.
Purpose:
- To outline the diagnostic approach for HES.
- To highlight the prognostic significance of organ involvement, particularly cardiac.
- To review current and emerging therapeutic strategies.
Summary:
- HES diagnosis necessitates identifying the specific cause and extent of organ damage.
- Cardiac involvement significantly worsens patient outcomes.
- Current treatments include glucocorticoids and steroid-sparing agents, with targeted therapies like tyrosine kinase inhibitors for specific causes.
Impact:
- Improved diagnostic work-up aids in tailored treatment selection.
- Understanding prognostic factors like cardiac involvement guides clinical management.
- Advances in molecular pathogenesis pave the way for novel therapies, including antibody treatments.
More Related Videos
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Nephrotic Syndrome I : Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Hyperosmolar Hyperglycemic State
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

